Have you ever wanted a transparent way to invest in the orthopaedic repair medical device sector? Or how about the autoimmune-inflammation pharmaceutical industry? If your answer to either of these questions is yes, then you're in luck. These are the niche sectors that New York-based financial products firm XShares hopes to target with its HealthShares exchange-traded fund (ETF) series.
The autoimmune-inflammation pharmaceutical ETF began trading on the New York Stock Exchange (NYSE) on March
The week on Risk.net, July 7-13, 2018Receive this by email